WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 (SCI-Expanded)
Background: The purpose of this study was to investigate plasma levels of thrombin activatable fibrinolysis inhibitor (TAFI) and TAFI's relationship with coagulation markers (prothrombin fragment 1 + 2) in gastric cancer patients.